Revised SPCs: Benlysta (belimumab) powder for concentrate for solution for infusion

SPC updated in relation to use in patients ≥65, based on interim results from a meta-analysis. SPC notes data on use in this age group are limited and it should be used with caution. Data from a large safety study has also been added, including information in infection risk.


electronic Medicines compendium